This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Novak, U. Articles by Lepperdingerm, G. Search for Related Content PubMed PubMed Citation Articles by Novak, U. Articles by Lepperdingerm, G.

Hyaluronidase-2 Overexpression Accelerates Intracerebral but not Subcutaneous Tumor Formation of Murine Astrocytoma Cells¹

Departments of Surgery [U. N., S. S. S., A. H. K.] and Neurosurgery [S. S. S., A. H. K.], The Royal Melbourne Hospital, University of Melbourne, Parkville, 3050 Victoria, Australia, and Institute of Molecular Biology, Austrian Academy of Sciences, A-5020 Salzburg, Austria [G. L.]

Gliomas are highly invasive, invariably fatal intracerebral tumors. It seems that receptors for hyaluronan are required for the invasive process. Hyaluronan is a major component of the extracellular matrix in the brain, and all of the gliomas express CD44, the principal receptor for hyaluronan. To investigate the role of lysosomal hyaluronidases on tumor invasion we overexpressed hyaluronidase-2 (HYAL2) in murine astrocytoma cells. We found that high expression of HYAL2 accelerated intracerebral tumor growth dramatically, whereas the same cells formed s.c. tumors within the same time as the parental cells. The brain tumors were highly vascularized and more invasive than the control tumors. It seems that the interactions of the HYAL2-expressing tumor cells with the hyaluronan-containing extracellular matrix in the brain mediate these effects, whereas the same cells in a s.c. environment, which lacks the high hyaluronan level, behave like the parental cells.

This article has been cited by other articles:

				H. Harada and M. Takahashi CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2 J. Biol. Chem., February 23, 2007; 282(8): 5597 - 5607. [Abstract] [Full Text] [PDF]

				A. Al'Qteishat, J. Gaffney, J. Krupinski, F. Rubio, D. West, S. Kumar, P. Kumar, N. Mitsios, and M. Slevin Changes in hyaluronan production and metabolism following ischaemic stroke in man Brain, August 1, 2006; 129(8): 2158 - 2176. [Abstract] [Full Text] [PDF]

				K. N. Sugahara, T. Hirata, H. Hayasaka, R. Stern, T. Murai, and M. Miyasaka Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments J. Biol. Chem., March 3, 2006; 281(9): 5861 - 5868. [Abstract] [Full Text] [PDF]

				L. Shiftan, T. Israely, M. Cohen, V. Frydman, H. Dafni, R. Stern, and M. Neeman Magnetic Resonance Imaging Visualization of Hyaluronidase in Ovarian Carcinoma Cancer Res., November 15, 2005; 65(22): 10316 - 10323. [Abstract] [Full Text] [PDF]

				G. Chow and W. Knudson Characterization of Promoter Elements of the Human HYAL-2 Gene J. Biol. Chem., July 22, 2005; 280(29): 26904 - 26912. [Abstract] [Full Text] [PDF]

				L. Y. W. Bourguignon, P. A. Singleton, F. Diedrich, R. Stern, and E. Gilad CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion J. Biol. Chem., June 25, 2004; 279(26): 26991 - 27007. [Abstract] [Full Text] [PDF]

				R. Stern Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology, December 1, 2003; 13(12): 105R - 115R. [Abstract] [Full Text] [PDF]

				C. L. Nutt, C. A. Zerillo, G. M. Kelly, and S. Hockfield Brain Enriched Hyaluronan Binding (BEHAB)/Brevican Increases Aggressiveness of CNS-1 Gliomas in Lewis Rats Cancer Res., October 1, 2001; 61(19): 7056 - 7059. [Abstract] [Full Text] [PDF]